Cargando…

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation

Dysfunctional triglyceride‐very low‐density lipoprotein (TG‐VLDL) metabolism is linked to metabolic‐associated fatty liver disease (MAFLD); however, the underlying cause remains unclear. The study shows that hepatic E3 ubiquitin ligase murine double minute 2 (MDM2) controls MAFLD by blocking TG‐VLDL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Huige, Wang, Lin, Liu, Zhuohao, Long, Kekao, Kong, Mengjie, Ye, Dewei, Chen, Xi, Wang, Kai, Wu, Kelvin KL, Fan, Mengqi, Song, Erfei, Wang, Cunchuan, Hoo, Ruby LC, Hui, Xiaoyan, Hallenborg, Philip, Piao, Hailong, Xu, Aimin, Cheng, Kenneth KY
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284139/ https://www.ncbi.nlm.nih.gov/pubmed/35524581 http://dx.doi.org/10.1002/advs.202200742

Ejemplares similares

The APPL1-Rab5 axis restricts NLRP3 inflammasome activation through early endosomal-dependent mitophagy in macrophages
por: Wu, Kelvin Ka Lok, et al.
Publicado: (2021)

The MDM2–p53–pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells
por: Li, Xiaomu, et al.
Publicado: (2016)

Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
por: Qiao, Liping, et al.
Publicado: (2008)

The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation
por: Mobin, Mehrpouya B., et al.
Publicado: (2016)

Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
por: Takahashi, Sadao
Publicado: (2017)

Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells
por: Wu, Xiaoping, et al.
Publicado: (2021)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins: LncRNA with HK1 regulates triglycerides, autophagy and VLDL
por: Wang, Lingling, et al.
Publicado: (2023)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Gene-environment interactions due to quantile-specific heritability of triglyceride and VLDL concentrations
por: Williams, Paul T.
Publicado: (2020)

Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis
por: Qiu, Han, et al.
Publicado: (2022)

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2014)

Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment
por: Samson, Clarissa E., et al.
Publicado: (2012)

Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
por: Timpson, Nicholas J., et al.
Publicado: (2015)

PMON31 IL-4 Serum Levels Correlate with Triglycerides and VLDL in African American males
por: Johnson, Abraham, et al.
Publicado: (2022)

The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL
por: van Dijk, Peter R., et al.
Publicado: (2019)

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat
por: Kabagambe, Edmond K., et al.
Publicado: (2012)

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes
por: Carlier, Aurélie, et al.
Publicado: (2020)

Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis
por: Zhang, Tianpeng, et al.
Publicado: (2020)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides
por: Rayner, Katey J., et al.
Publicado: (2011)

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)

VLDL-associated mutagenic activity.
por: Gomes, M. I., et al.
Publicado: (1982)

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
por: Meyers, Charles Daniel, et al.
Publicado: (2015)

Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome
por: Broedl, Uli C, et al.
Publicado: (2006)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

Adipose MDM2 regulates systemic insulin sensitivity
por: Hallenborg, Philip, et al.
Publicado: (2021)

A Pilot Trial: Fish Oil and Metformin Effects on ApoB-Remnants and Triglycerides in Women With Polycystic Ovary Syndrome
por: Vine, Donna, et al.
Publicado: (2021)

MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3
por: Hallenborg, P, et al.
Publicado: (2016)

Macrophages take up VLDL-sized emulsion particles through caveolae-mediated endocytosis and excrete part of the internalized triglycerides as fatty acids
por: Deng, Lei, et al.
Publicado: (2022)

A Comparison of Lipids and apoB in Asian Indians and Americans
por: Singh, Kavita, et al.
Publicado: (2021)

Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
por: Di Filippo, Mathilde, et al.
Publicado: (2014)

Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Chylomicron and VLDL Synthesis and Secretion in Caco-2 Cells
por: Wang, Yue, et al.
Publicado: (2014)

Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
por: Li, Bo-Tao, et al.
Publicado: (2020)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB
por: Khoo, Bernard, et al.
Publicado: (2007)

Effects of Electronegative VLDL on Endothelium Damage in Metabolic Syndrome
por: Chen, Chu-Huang, et al.
Publicado: (2012)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
por: Krauss, Ronald M., et al.
Publicado: (2023)

Correction: Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_meo51vkfg1hgl5b0gq8ljml4u9